Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 318 (5853): 1108-1113

Copyright © 2007 by the American Association for the Advancement of Science

The Genomic Landscapes of Human Breast and Colorectal Cancers

Laura D. Wood,1* D. Williams Parsons,1* Siân Jones,1* Jimmy Lin,1* Tobias Sjöblom,1*{dagger} Rebecca J. Leary,1 Dong Shen,1 Simina M. Boca,1,2 Thomas Barber,1{ddagger} Janine Ptak,1 Natalie Silliman,1 Steve Szabo,1 Zoltan Dezso,3 Vadim Ustyanksky,3 Tatiana Nikolskaya,3,4 Yuri Nikolsky,3 Rachel Karchin,5 Paul A. Wilson,5 Joshua S. Kaminker,6 Zemin Zhang,6 Randal Croshaw,7 Joseph Willis,8 Dawn Dawson,8 Michail Shipitsin,9 James K. V. Willson,10 Saraswati Sukumar,11 Kornelia Polyak,9 Ben Ho Park,11 Charit L. Pethiyagoda,12 P. V. Krishna Pant,12 Dennis G. Ballinger,12 Andrew B. Sparks,12§ James Hartigan,13 Douglas R. Smith,13 Erick Suh,13 Nickolas Papadopoulos,1 Phillip Buckhaults,7 Sanford D. Markowitz,14 Giovanni Parmigiani,1|| Kenneth W. Kinzler,1|| Victor E. Velculescu,1|| Bert Vogelstein1||

Abstract: Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we isolated DNA from 11 breast and 11 colorectal tumors and determined the sequences of the genes in the Reference Sequence database in these samples. Based on analysis of exons representing 20,857 transcripts from 18,191 genes, we conclude that the genomic landscapes of breast and colorectal cancers are composed of a handful of commonly mutated gene "mountains" and a much larger number of gene "hills" that are mutated at low frequency. We describe statistical and bioinformatic tools that may help identify mutations with a role in tumorigenesis. These results have implications for understanding the nature and heterogeneity of human cancers and for using personal genomics for tumor diagnosis and therapy.

1 The Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.
2 Department of Biostatistics, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.
3 GeneGo, St. Joseph, MI 49085, USA.
4 Vavilov Institute of General Genetics, Moscow, Russia.
5 Department of Biomedical Engineering, Institute of Computational Medicine, Johns Hopkins University, Baltimore, MD 21218, USA.
6 Department of Bioinformatics, Genentech, San Francisco, CA 94080, USA.
7 Department of Pathology and Microbiology, The Center for Colon Cancer Research, and The South Carolina Cancer Center, Division of Basic Research, The University of South Carolina, School of Medicine, Columbia, SC 29229, USA.
8 Department of Pathology and Ireland Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.
9 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
10 Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
11 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
12 Perlegen Sciences, Mountain View, CA 94043, USA.
13 Agencourt Bioscience Corporation, Beverly, MA 01915, USA.
14 Department of Medicine and Ireland Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, and Howard Hughes Medical Institute, Cleveland, OH 44106, USA.

* These authors contributed equally to this work.

{dagger} Present address: Department of Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.

{ddagger} Present address: Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN 42685, USA.

§ Present address: Complete Genomics, Sunnyvale, CA 94085, USA.

|| To whom correspondence should be addressed. E-mail: gp{at}jhu.edu (G.P.); kinzlke{at}jhmi.edu (K.W.K.); velculescu{at}jhmi.edu (V.E.V.); vogelbe{at}welch.jhu.edu (B.V.)


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.
J. E. Grim (2014)
Gut 63, 707-709
   Full Text »    PDF »
Network-based global inference of human disease genes.
X. Wu, R. Jiang, M. Q. Zhang, and S. Li (2014)
Mol Syst Biol 4, 189
   Abstract »    Full Text »    PDF »
RNA editing in RHOQ promotes invasion potential in colorectal cancer.
S.-W. Han, H.-P. Kim, J.-Y. Shin, E.-G. Jeong, W.-C. Lee, K. Y. Kim, S. Y. Park, D.-W. Lee, J.-K. Won, S.-Y. Jeong, et al. (2014)
J. Exp. Med. 211, 613-621
   Abstract »    Full Text »    PDF »
Masking Epistasis Between MYC and TGF-{beta} Pathways in Antiangiogenesis-Mediated Colon Cancer Suppression.
M. Dews, G. S. Tan, S. Hultine, P. Raman, J. Choi, E. K. Duperret, J. Lawler, A. Bass, and A. Thomas-Tikhonenko (2014)
J Natl Cancer Inst 106, dju043
   Abstract »    Full Text »    PDF »
Profiling Cancer Gene Mutations in Clinical Formalin-Fixed, Paraffin-Embedded Colorectal Tumor Specimens Using Targeted Next-Generation Sequencing.
L. Zhang, L. Chen, S. Sah, G. J. Latham, R. Patel, Q. Song, H. Koeppen, R. Tam, E. Schleifman, H. Mashhedi, et al. (2014)
Oncologist 19, 336-343
   Abstract »    Full Text »    PDF »
Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.
J. Reimand and G. D. Bader (2014)
Mol Syst Biol 9, 637
   Abstract »    Full Text »    PDF »
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes.
O. An, V. Pendino, M. D'Antonio, E. Ratti, M. Gentilini, and F. D. Ciccarelli (2014)
Database 2014, bau015
   Abstract »    Full Text »    PDF »
Twist1-induced dissemination preserves epithelial identity and requires E-cadherin.
E. R. Shamir, E. Pappalardo, D. M. Jorgens, K. Coutinho, W.-T. Tsai, K. Aziz, M. Auer, P. T. Tran, J. S. Bader, and A. J. Ewald (2014)
J. Cell Biol. 204, 839-856
   Abstract »    Full Text »    PDF »
Tumor heterogeneity in the clinic: is it a real problem?.
F. Janku (2014)
Therapeutic Advances in Medical Oncology 6, 43-51
   Abstract »    PDF »
Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
J. Zhang, J. Liu, J. Sun, C. Chen, G. Foltz, and B. Lin (2014)
Brief Bioinform 15, 244-255
   Abstract »    Full Text »    PDF »
{beta}-Catenin Promotes Colitis and Colon Cancer Through Imprinting of Proinflammatory Properties in T Cells.
S. Keerthivasan, K. Aghajani, M. Dose, L. Molinero, M. W. Khan, V. Venkateswaran, C. Weber, A. O. Emmanuel, T. Sun, D. J. Bentrem, et al. (2014)
Science Translational Medicine 6, 225ra28
   Abstract »    Full Text »    PDF »
Interaction-based discovery of functionally important genes in cancers.
D. Ghersi and M. Singh (2014)
Nucleic Acids Res. 42, e18
   Abstract »    Full Text »    PDF »
Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/{beta}-Catenin Signaling.
B.-S. Moon, W.-J. Jeong, J. Park, T. I. Kim, D. S. Min, and K.-Y. Choi (2014)
J Natl Cancer Inst 106, djt373
   Abstract »    Full Text »    PDF »
Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects.
K. G. Griewank, R. A. Scolyer, J. F. Thompson, K. T. Flaherty, D. Schadendorf, and R. Murali (2014)
J Natl Cancer Inst 106, djt435
   Abstract »    Full Text »    PDF »
Temporal Production of the Signaling Lipid Phosphatidic Acid by Phospholipase D2 Determines the Output of Extracellular Signal-Regulated Kinase Signaling in Cancer Cells.
F. Zhang, Z. Wang, M. Lu, Y. Yonekubo, X. Liang, Y. Zhang, P. Wu, Y. Zhou, S. Grinstein, J. F. Hancock, et al. (2014)
Mol. Cell. Biol. 34, 84-95
   Abstract »    Full Text »    PDF »
Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair.
P. J. Halvey, X. Wang, J. Wang, A. A. Bhat, P. Dhawan, M. Li, B. Zhang, D. C. Liebler, and R. J. C. Slebos (2014)
Cancer Res. 74, 387-397
   Abstract »    Full Text »    PDF »
The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
A. Escudero-Esparza, N. Kalchishkova, E. Kurbasic, W. G. Jiang, and A. M. Blom (2013)
FASEB J 27, 5083-5093
   Abstract »    Full Text »    PDF »
Central Role of RET in Thyroid Cancer.
M. Santoro and F. Carlomagno (2013)
Cold Spring Harb Perspect Biol 5, a009233
   Abstract »    Full Text »    PDF »
BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors.
D. Zecchin, V. Boscaro, E. Medico, L. Barault, M. Martini, S. Arena, C. Cancelliere, A. Bartolini, E. H. Crowley, A. Bardelli, et al. (2013)
Mol. Cancer Ther. 12, 2950-2961
   Abstract »    Full Text »    PDF »
The future of colorectal cancer: implications of screening.
M. Neerincx, T. E. Buffart, C. J. J. Mulder, G. A. Meijer, and H. M. W. Verheul (2013)
Gut 62, 1387-1389
   Full Text »    PDF »
p120catenin alteration in cancer and its role in tumour invasion.
F. Peglion and S. Etienne-Manneville (2013)
Phil Trans R Soc B 368, 20130015
   Abstract »    Full Text »    PDF »
Cancer heterogeneity--a multifaceted view.
F. D. S. E. Melo, L. Vermeulen, E. Fessler, and J. P. Medema (2013)
EMBO Rep. 14, 686-695
   Abstract »    Full Text »    PDF »
High Cyclooxygenase-2 Expression Is Associated with Advanced Stages in Colorectal Cancer.
A. ELZAGHEID, F. EMAETIG, L. ALKIKHIA, A. BUHMEIDA, K. SYRJANEN, O. EL-FAITORI, M. LATTO, Y. COLLAN, and S. PYRHONEN (2013)
Anticancer Res 33, 3137-3143
   Abstract »    Full Text »    PDF »
Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma.
P. Estevez-Garcia, I. Lopez-Calderero, S. Molina-Pinelo, S. Munoz-Galvan, A. Salinas, L. Gomez-Izquierdo, A. Lucena-Cacace, B. Felipe-Abrio, L. Paz-Ares, R. Garcia-Carbonero, et al. (2013)
Clin. Cancer Res. 19, 3925-3935
   Abstract »    Full Text »    PDF »
From human genome to cancer genome: The first decade.
D. A. Wheeler and L. Wang (2013)
Genome Res. 23, 1054-1062
   Abstract »    Full Text »    PDF »
Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines.
N. Hacohen, E. F. Fritsch, T. A. Carter, E. S. Lander, and C. J. Wu (2013)
Cancer Immunology 1, 11-15
   Abstract »    Full Text »    PDF »
An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer.
Z. Wen, Z.-P. Liu, Z. Liu, Y. Zhang, and L. Chen (2013)
JAMIA 20, 659-667
   Abstract »    Full Text »    PDF »
Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
E. A. Nizialek, C. Peterson, J. L. Mester, E. Downes-Kelly, and C. Eng (2013)
Hum. Mol. Genet. 22, 2451-2461
   Abstract »    Full Text »    PDF »
Systematic tracking of dysregulated modules identifies novel genes in cancer.
S. Srihari and M. A. Ragan (2013)
Bioinformatics 29, 1553-1561
   Abstract »    Full Text »    PDF »
Next generation sequencing and a new era of medicine.
G. Casey, D. Conti, R. Haile, and D. Duggan (2013)
Gut 62, 920-932
   Full Text »    PDF »
Mouse Models of Kras-Mutant Colorectal Cancer: Valuable GEMMs for Drug Testing?.
F. Di Nicolantonio and A. Bardelli (2013)
Clin. Cancer Res. 19, 2794-2796
   Abstract »    Full Text »    PDF »
Genomic insights into cancer-associated aberrant CpG island hypermethylation.
D. Sproul and R. R. Meehan (2013)
Briefings in Functional Genomics 12, 174-190
   Abstract »    Full Text »    PDF »
Molecular Dissection of Microsatellite Instable Colorectal Cancer.
E. Vilar and J. Tabernero (2013)
Cancer Discovery 3, 502-511
   Abstract »    Full Text »    PDF »
Relationship Between Circulating Tumor Cells and Peripheral T-Cells in Patients with Primary Breast Cancer.
I. GRUBER, N. LANDENBERGER, A. STAEBLER, M. HAHN, D. WALLWIENER, and T. FEHM (2013)
Anticancer Res 33, 2233-2238
   Abstract »    Full Text »    PDF »
A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer.
S. M. Singel, C. Cornelius, K. Batten, G. Fasciani, W. E. Wright, L. Lum, and J. W. Shay (2013)
Clin. Cancer Res. 19, 2061-2070
   Abstract »    Full Text »    PDF »
Aneuploidy in health, disease, and aging.
R. M. Ricke and J. M. van Deursen (2013)
J. Cell Biol. 201, 11-21
   Abstract »    Full Text »    PDF »
N-Glycoprotein SRMAtlas: A RESOURCE OF MASS SPECTROMETRIC ASSAYS FOR N-GLYCOSITES ENABLING CONSISTENT AND MULTIPLEXED PROTEIN QUANTIFICATION FOR CLINICAL APPLICATIONS.
R. Huttenhain, S. Surinova, R. Ossola, Z. Sun, D. Campbell, F. Cerciello, R. Schiess, D. Bausch-Fluck, G. Rosenberger, J. Chen, et al. (2013)
Mol. Cell. Proteomics 12, 1005-1016
   Abstract »    Full Text »    PDF »
Cancer Genome Landscapes.
B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz Jr., and K. W. Kinzler (2013)
Science 339, 1546-1558
   Abstract »    Full Text »    PDF »
MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1).
D. Sun, F. Yu, Y. Ma, R. Zhao, X. Chen, J. Zhu, C.-Y. Zhang, J. Chen, and J. Zhang (2013)
J. Biol. Chem. 288, 9508-9518
   Abstract »    Full Text »    PDF »
Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice.
H. Kamiyama, S. Rauenzahn, J. S. Shim, C. A. Karikari, G. Feldmann, L. Hua, M. Kamiyama, F. W. Schuler, M.-T. Lin, R. M. Beaty, et al. (2013)
Clin. Cancer Res. 19, 1139-1146
   Abstract »    Full Text »    PDF »
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes.
B. A. Smith, D. N. Shelton, C. Kieffer, B. Milash, J. Usary, C. M. Perou, P. S. Bernard, and B. E. Welm (2013)
Genes & Cancer
   Abstract »    Full Text »    PDF »
The cancer antigenome.
B. Heemskerk, P. Kvistborg, and T. N. M. Schumacher (2013)
EMBO J. 32, 194-203
   Abstract »    Full Text »    PDF »
Genetic heterogeneity of diffuse large B-cell lymphoma.
J. Zhang, V. Grubor, C. L. Love, A. Banerjee, K. L. Richards, P. A. Mieczkowski, C. Dunphy, W. Choi, W. Y. Au, G. Srivastava, et al. (2013)
PNAS 110, 1398-1403
   Abstract »    Full Text »    PDF »
Exploring functional variant discovery in non-coding regions with SInBaD.
K.-V. Lehmann and T. Chen (2013)
Nucleic Acids Res. 41, e7
   Abstract »    Full Text »    PDF »
Genomic Medicine: New Frontiers and New Challenges.
M. D. Pasic, S. Samaan, and G. M. Yousef (2013)
Clin. Chem. 59, 158-167
   Abstract »    Full Text »    PDF »
Reflections on the Founding of the International Cancer Genome Consortium.
J. Jennings and T. J. Hudson (2013)
Clin. Chem. 59, 18-21
   Full Text »    PDF »
Extensive somatic L1 retrotransposition in colorectal tumors.
S. Solyom, A. D. Ewing, E. P. Rahrmann, T. Doucet, H. H. Nelson, M. B. Burns, R. S. Harris, D. F. Sigmon, A. Casella, B. Erlanger, et al. (2012)
Genome Res. 22, 2328-2338
   Abstract »    Full Text »    PDF »
A novel missense-mutation-related feature extraction scheme for 'driver' mutation identification.
H. Tan, J. Bao, and X. Zhou (2012)
Bioinformatics 28, 2948-2955
   Abstract »    Full Text »    PDF »
CDX2 is an amplified lineage-survival oncogene in colorectal cancer.
K. Salari, M. E. Spulak, J. Cuff, A. D. Forster, C. P. Giacomini, S. Huang, M. E. Ko, A. Y. Lin, M. van de Rijn, and J. R. Pollack (2012)
PNAS 109, E3196-E3205
   Abstract »    Full Text »    PDF »
Key Roles for the Lipid Signaling Enzyme Phospholipase D1 in the Tumor Microenvironment During Tumor Angiogenesis and Metastasis.
Q. Chen, T. Hongu, T. Sato, Y. Zhang, W. Ali, J.-A. Cavallo, A. van der Velden, H. Tian, G. Di Paolo, B. Nieswandt, et al. (2012)
Science Signaling 5, ra79
   Abstract »    Full Text »    PDF »
Functional impact bias reveals cancer drivers.
A. Gonzalez-Perez and N. Lopez-Bigas (2012)
Nucleic Acids Res. 40, e169
   Abstract »    Full Text »    PDF »
DNA polymerase {beta} variant Ile260Met generates global gene expression changes related to cellular transformation.
K. A. Donigan, D. Tuck, V. Schulz, and J. B. Sweasy (2012)
Mutagenesis 27, 683-691
   Abstract »    Full Text »    PDF »
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
A. H. Sillars-Hardebol, B. Carvalho, M. Tijssen, J. A. M. Belien, M. de Wit, P. M. Delis-van Diemen, F. Ponten, M. A. van de Wiel, R. J. A. Fijneman, and G. A. Meijer (2012)
Gut 61, 1568-1575
   Abstract »    Full Text »    PDF »
Integrative functional genomics identifies RINT1 as a novel GBM oncogene.
S. N. Quayle, M. G. Chheda, S. A. Shukla, R. Wiedemeyer, P. Tamayo, R. W. Dewan, L. Zhuang, E. Huang-Hobbs, S. Haidar, Y. Xiao, et al. (2012)
Neuro Oncology 14, 1325-1331
   Abstract »    Full Text »    PDF »
Antitumoral and Mechanistic Studies of Ianthelline Isolated from the Arctic Sponge Stryphnus fortis.
K. O. HANSSEN, J. H. ANDERSEN, T. STIBERG, R. A. ENGH, J. SVENSON, A.-M. GENEVIeRE, and E. HANSEN (2012)
Anticancer Res 32, 4287-4297
   Abstract »    Full Text »    PDF »
Molecular Pathways: Context-Dependent Approaches to Notch Targeting as Cancer Therapy.
A. M. Egloff and J. R. Grandis (2012)
Clin. Cancer Res. 18, 5188-5195
   Abstract »    Full Text »    PDF »
ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium.
K.-V. Nguyen-Ngoc, K. J. Cheung, A. Brenot, E. R. Shamir, R. S. Gray, W. C. Hines, P. Yaswen, Z. Werb, and A. J. Ewald (2012)
PNAS 109, E2595-E2604
   Abstract »    Full Text »    PDF »
Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
R. A. Beckman, G. S. Schemmann, and C.-H. Yeang (2012)
PNAS 109, 14586-14591
   Abstract »    Full Text »    PDF »
Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
M. Yu and W. M. Grady (2012)
Therapeutic Advances in Gastroenterology 5, 319-337
   Abstract »    PDF »
Cancer Immunotherapy by Intratumoral Injection of {alpha}-gal Glycolipids.
G. F. WHALEN, M. SULLIVAN, B. PIPERDI, W. WASSEFF, and U. GALILI (2012)
Anticancer Res 32, 3861-3868
   Abstract »    Full Text »    PDF »
Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis.
A. M. Dulak, S. E. Schumacher, J. van Lieshout, Y. Imamura, C. Fox, B. Shim, A. H. Ramos, G. Saksena, S. C. Baca, J. Baselga, et al. (2012)
Cancer Res. 72, 4383-4393
   Abstract »    Full Text »    PDF »
International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data.
J. Zhang, J. Baran, A. Cros, J. M. Guberman, S. Haider, J. Hsu, Y. Liang, E. Rivkin, J. Wang, B. Whitty, et al. (2012)
Database 2011, bar026
   Abstract »    Full Text »    PDF »
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.
N. A. Saunders, F. Simpson, E. W. Thompson, M. M. Hill, L. Endo-Munoz, G. Leggatt, R. F. Minchin, and A. Guminski (2012)
EMBO Mol Med. 4, 675-684
   Abstract »    Full Text »    PDF »
Identification of five novel modifier loci of ApcMin harbored in the BXH14 recombinant inbred strain.
S. C. Nnadi, R. Watson, J. Innocent, G. E. Gonye, A. M. Buchberg, and L. D. Siracusa (2012)
Carcinogenesis
   Abstract »    Full Text »    PDF »
Clonal competition with alternating dominance in multiple myeloma.
J. J. Keats, M. Chesi, J. B. Egan, V. M. Garbitt, S. E. Palmer, E. Braggio, S. Van Wier, P. R. Blackburn, A. S. Baker, A. Dispenzieri, et al. (2012)
Blood 120, 1067-1076
   Abstract »    Full Text »    PDF »
Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance.
M. P. Alcolea, P. Casado, J.-C. Rodriguez-Prados, B. Vanhaesebroeck, and P. R. Cutillas (2012)
Mol. Cell. Proteomics 11, 453-466
   Abstract »    Full Text »    PDF »
Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model.
H. Herranz, X. Hong, N. T. Hung, P. M. Voorhoeve, and S. M. Cohen (2012)
Genes & Dev. 26, 1602-1611
   Abstract »    Full Text »    PDF »
Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics.
R. Huttenhain, M. Soste, N. Selevsek, H. Rost, A. Sethi, C. Carapito, T. Farrah, E. W. Deutsch, U. Kusebauch, R. L. Moritz, et al. (2012)
Science Translational Medicine 4, 142ra94
   Abstract »    Full Text »    PDF »
Haploinsufficient Gene Selection in Cancer.
C. D. Greenman (2012)
Science 337, 47-48
   Abstract »    Full Text »    PDF »
Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.
A. Youn and R. Simon (2012)
Bioinformatics 28, 1555-1561
   Abstract »    Full Text »    PDF »
Molecular Testing in Colorectal Cancer: Diagnosis of Lynch Syndrome and Personalized Cancer Medicine.
C. Shi and K. Washington (2012)
Am J Clin Pathol 137, 847-859
   Abstract »    Full Text »    PDF »
Fbw7 and p53 Cooperatively Suppress Advanced and Chromosomally Unstable Intestinal Cancer.
J. E. Grim, S. E. Knoblaugh, K. A. Guthrie, A. Hagar, J. Swanger, J. Hespelt, J. J. Delrow, T. Small, W. M. Grady, K. I. Nakayama, et al. (2012)
Mol. Cell. Biol. 32, 2160-2167
   Abstract »    Full Text »    PDF »
Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family.
E. P. Bennett, U. Mandel, H. Clausen, T. A. Gerken, T. A. Fritz, and L. A. Tabak (2012)
Glycobiology 22, 736-756
   Abstract »    Full Text »    PDF »
On Oncogenes and Tumor Suppressor Genes in the Mammary Gland.
R. M. Perera and N. Bardeesy (2012)
Cold Spring Harb Perspect Biol 4, a013466
   Full Text »    PDF »
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.
T. Bhatla, J. Wang, D. J. Morrison, E. A. Raetz, M. J. Burke, P. Brown, and W. L. Carroll (2012)
Blood 119, 5201-5210
   Abstract »    Full Text »    PDF »
Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer.
B. Akhtar-Zaidi, R. Cowper-Sal{middle dot}lari, O. Corradin, A. Saiakhova, C. F. Bartels, D. Balasubramanian, L. Myeroff, J. Lutterbaugh, A. Jarrar, M. F. Kalady, et al. (2012)
Science 336, 736-739
   Abstract »    Full Text »    PDF »
New methods for finding common insertion sites and co-occurring common insertion sites in transposon- and virus-based genetic screens.
T. L. Bergemann, T. K. Starr, H. Yu, M. Steinbach, J. Erdmann, Y. Chen, R. T. Cormier, D. A. Largaespada, and K. A. T. Silverstein (2012)
Nucleic Acids Res. 40, 3822-3833
   Abstract »    Full Text »    PDF »
The DNA translocase activity of FANCM protects stalled replication forks.
A. N. Blackford, R. A. Schwab, J. Nieminuszczy, A. J. Deans, S. C. West, and W. Niedzwiedz (2012)
Hum. Mol. Genet. 21, 2005-2016
   Abstract »    Full Text »    PDF »
Oncogenomics Methods and Resources.
S. J. Furney, G. Gundem, and N. Lopez-Bigas (2012)
Cold Spring Harb Protoc 2012, pdb.top069229
   Abstract »    Full Text »    PDF »
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.
K. M. Mann, J. M. Ward, C. C. K. Yew, A. Kovochich, D. W. Dawson, M. A. Black, B. T. Brett, T. E. Sheetz, A. J. Dupuy, Australian Pancreatic Cancer Genome Initiative, et al. (2012)
PNAS 109, 5934-5941
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882